NIH: Precision T-cell Therapy Stalls Treatment-resistant Cancers in Clinical Trial
October 24, 2026
October 24, 2026
WASHINGTON, Oct. 24 (TNSjou) -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release:
* * *
October 23, 2026
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
Experimental drug invika halts progression of refractory tumors by selectively stimulating tumor-fighting T cells.
-
Early results of the first clinical trial to evaluate t . . .
* * *
October 23, 2026
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
Experimental drug invika halts progression of refractory tumors by selectively stimulating tumor-fighting T cells.
-
Early results of the first clinical trial to evaluate t . . .